KYKOF News and Press, Kyowa Hakko Kogyo

2024-06-17 10:40:00 ET Summary Shionogi optioned rights for two candidates targeting cochlear synaptopathy, including one that is poised to start a Phase II trial. XtalPi raised US$126.8 million in a Hong Kong IPO, the third-largest Hong Kong IPO of the year. Takeda entered a ...

2024-05-07 09:40:01 ET More on Kyowa Kirin Kyowa Kirin’s rare disease therapy becomes world’s most expensive drug Kyowa buyout Orchard wins FDA nod for rare disease therapy Historical earnings data for Kyowa Kirin Dividend scorecard for Kyowa Ki...

2024-03-20 12:11:15 ET More on Kyowa Kirin Kyowa buyout Orchard wins FDA nod for rare disease therapy Historical earnings data for Kyowa Kirin Dividend scorecard for Kyowa Kirin Financial information for Kyowa Kirin Read the full article on Seeking ...

2024-03-19 10:44:51 ET More on Kyowa Kirin Historical earnings data for Kyowa Kirin Dividend scorecard for Kyowa Kirin Financial information for Kyowa Kirin Historical earnings data for Kyowa Kirin Co., Ltd. Financial information for Kyowa Kirin Co., ...

2024-02-07 17:44:04 ET More on Kyowa Kirin Historical earnings data for Kyowa Kirin Dividend scorecard for Kyowa Kirin Financial information for Kyowa Kirin Read the full article on Seeking Alpha For further details see: Kyowa Kirin reports FY res...

2023-12-14 12:30:25 ET The Biden administration on Thursday named 48 Medicare Part B drugs that could be subject to inflation penalties for Q1 2024, including products from the likes of AbbVie ( NYSE: ABBV ), Amgen ( NASDAQ: AMGN ), and Pfizer ( NYSE: PFE ). Drug...

2023-12-04 07:02:21 ET Summary Kyowa Kirin is acquiring Orchard Therapeutics for $16 per share and a CVR worth up to $1, adding up to a $350 million deal. The acquisition comes after extensive research collaboration and will allow Kyowa to accelerate research programs. The CVR...

2023-11-01 10:27:34 ET More on Kyowa Kirin Kyowa Kirin: High-Risk High-Return Call Reiterating Our Buy Rating Ardelyx gains as Japan approves kidney disease therapy Historical earnings data for Kyowa Kirin Dividend scorecard for Kyowa Kirin Financial ...

2023-10-31 14:29:47 ET More on Ardelyx Ardelyx, Inc. (ARDX) Q3 2023 Earnings Call Transcript Ardelyx: XPHOZAH Is No Niche Product Rising Sun Over Ardelyx: A Tenapanor Tale (Rating Upgrade) Biggest stock movers today: Morgan Stanley, Spirit AeroSystems, United...

2023-10-05 05:48:00 ET NASDAQ: RIVN plunged more than 9% Related stories BlackBerry Limited (BB) Q2 2024 Earnings Call Transcript Does Rivian Still Have An Existential Crisis? BlackBerry Earnings Preview: Pre-Announcement May Not Save Further Sell-Off ...